TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

44.70$ -6.3% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 150 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VCYT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
19 18 16 18 18 20 20 23 23 26 30 30 31 30 31 21 31 35 37 55 60 67 68 73 76 80 82 90 90 98 97 114 116 119 114 130 132 141 139 150 562
6.4 6.5 6.3 7.0 7.2 7.8 7.9 8.2 8.3 8.7 8.5 8.8 9.1 10 12 7.7 10 11 12 17 22 23 24 25 26 27 26 35 28 29 34 37 37 40 35 40 41 36 38 42 157
12 12 10 11 10 12 12 15 15 17 21 21 22 20 19 13 21 23 24 38 39 44 44 48 50 53 56 56 62 69 62 78 79 79 80 90 91 105 101 109 405
1.8 3.6 1.7 1.4 0.8 3.2 1.1 2.2 1.2 3.1 3.4 3.3 3.6 4.4 4.4 4.2 1.0 4.6 5.3 6.2 8.0 25 9.2 9.4 11 11 13 13 13 19 16 16 18 19 18 16 16 21 27 29 93
7.9 5.7 8.3 8.4 7.2 5.4 7.8 7.8 7.4 6.6 6.5 6.6 6.3 8.2 20 7.6 11 12 59 29 36 3.8 39 37 18 37 40 43 16 41 43 47 40 47 52 14 43 1.4 24 27 96
17 15 18 18 17 18 21 20 20 20 23 24 24 28 31 24 25 31 70 45 55 57 59 59 59 59 67 64 94 104 67 73 67 75 77 95 68 79 77 86 309
-4.9 -3.7 -7.5 -6.6 -6.4 -6.0 -9.0 -5.9 -4.3 -3.1 -2.1 -3.1 -1.8 -8.2 -12 -11 -4.1 -8.1 -45 -7.5 -17 -12 -15 -11 -9.7 -5.4 -10 -8.1 -32 -36 -4.7 4.6 12 4.2 2.9 -5.3 23 26 24 23 96
0.8 0.8 0.8 0.8 0.8 2.5 0.4 0.5 0.5 0.5 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-5.6 -4.4 -8.2 -7.3 -7.0 -8.4 -9.2 -6.2 -4.5 -3.1 -1.9 -2.5 -0.7 -7.5 -12 -11 -4.1 -8.0 -46 -9.2 -15 -11 -14 -9.6 -8.9 -3.4 -8.1 -8.3 -30 -30 -1.9 7.4 17 3.4 7.4 1.3 19 41 30 19 109
0.8 0.9 0.9 0.9 0.9 2.6 0.7 0.6 0.8 1.0 0.8 1.1 1.1 0.9 0.6 0.2 0.1 0.1 -3.8 -0.2 -1.4 -0.8 0.0 -0.1 -0.2 0.4 -2.4 0.1 -0.2 -2.2 0.0 1.6 1.7 -1.7 0.4 2.2 -0.2 -0.5 1.3 -6.0 -5.5
-5.6 -4.4 -8.2 -7.3 -7.0 -8.4 -9.2 -6.2 -4.5 -3.1 -1.9 -2.5 -0.7 -7.5 -12 -11 -4.1 -8.0 -42 -9.0 -14 -11 -14 -9.5 -8.7 -3.8 -8.1 -8.4 -30 -28 -1.9 5.7 15 5.1 7.0 -1.0 19 41 29 25 114
-3.9 -3.3 -6.5 -5.5 -5.2 -6.5 -7.7 -4.8 -3.0 -1.6 -0.7 -1.3 0.3 -6.1 -9.7 -9.0 -2.1 -6.0 -43 -4.6 -9.3 -4.8 -7.8 -3.1 -1.6 3.1 -1.4 -1.4 -22 -24 1.9 13 23 9.7 6.5 6.7 24 46 35 24 130

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?